Latest news with #Alaris
Yahoo
25-07-2025
- Business
- Yahoo
Earnings Preview: What to Expect From Becton, Dickinson and Company's Report
Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. Valued at $52.3 billion by market cap, the company offers solutions that help advance medical research and genomics, enhance the diagnosis of infectious diseases and cancer, improve medication management, and promote infection prevention. The global medical technology giant is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Thursday, Aug. 7. Ahead of the event, analysts expect BDX to report a profit of $3.42 per share on a diluted basis, down 2.3% from $3.50 per share in the year-ago quarter. The company has consistently surpassed Wall Street's EPS estimates in its last four quarterly reports. More News from Barchart UnitedHealth Stock Spirals Lower Again. Don't Buy the Dip. This Self-Driving Car Stock Is Surging on a Major Nvidia Boost Auto Revenue Keeps Plunging at Tesla. Should You Buy the TSLA Stock Dip or Run Far Away? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. For the full year, analysts expect BDX to report EPS of $14.17, up 7.8% from $13.14 in fiscal 2024. Its EPS is expected to rise 3.4% year over year to $14.65 in fiscal 2026. BDX stock has significantly underperformed the S&P 500 Index's ($SPX) 17.3% gains over the past 52 weeks, with shares down 22.6% during this period. Similarly, it underperformed the Health Care Select Sector SPDR Fund's (XLV) 9.4% dip over the same time frame. BDX's underperformance is attributed to a software recall in its Alaris infusion pump systems. Software issues in the Alaris Systems Manager and Care Coordination Engine Infusion Adapter can cause delayed responses and potentially incorrect therapy administration, posing risks to patient safety. The recall affects critical components that integrate the pump with hospital electronic medical record systems. On May 1, BDX shares closed down more than 18% after reporting its Q2 results. Its adjusted EPS of $3.35 exceeded Wall Street's expectations of $3.28. The company's revenue was $5.3 billion, falling short of Wall Street forecasts of $5.4 billion. BDX expects full-year adjusted EPS in the range of $14.06 to $14.34, and expects revenue in the range of $21.8 billion to $21.9 billion. Analysts' consensus opinion on BDX stock is reasonably bullish, with an overall 'Moderate Buy' rating. Out of 17 analysts covering the stock, seven advise a 'Strong Buy' rating, one suggests a 'Moderate Buy,' and nine give a 'Hold.' BDX's average analyst price target is $213.71, indicating a potential upside of 16.4% from the current levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
10-07-2025
- Business
- Yahoo
BD appoints Bilal Muhsin as president of new connected care group
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Name: Bilal Muhsin New role: President of connected care, BD Previous role: Chief operating officer, Masimo BD said Monday that it has named Bilal Muhsin as president of its new connected care segment. The hire is effective as of July 2. The company is creating the segment as part of the restructuring it announced in February. Connected care will house BD's medication management and advanced patient monitoring devices, giving it control of products including the Pyxis line of automated dispensing systems and Alaris infusion pumps. Muhsin has joined BD to help set up the new segment. Reporting to BD CEO Tom Polen, the executive will lead strategy development to support the transition to the revised structure over the next several months. Polen said in a statement that Muhsin's 'extensive and deep knowledge of connected care technologies, software and informatics strategies' will help BD as it advances its connected care strategy. Muhsin developed the knowledge during his 25 years at Masimo, a medtech company that built a portfolio of patient monitoring devices around pulse oximeter technology. Masimo told investors last month that Muhsin was resigning as chief operating officer to pursue other opportunities. The company, which did not replace Muhsin when he left on July 1, disclosed the change alongside an overhaul of its commercial leadership. At BD, Muhsin will take over a connected care business that the company has grown through deals such as the $1.53 billion buyout of Parata Systems and $93 million acquisition of Medkeeper. The pharmacy robotics business that BD has built through the recent acquisitions sits alongside the Pyxis franchise that the company added to its portfolio through the $12.2 billion takeover of Carefusion in 2015. The Pyxis business received a warning letter from the Food and Drug Administration last year and is now entering an important period. BD recently began shipping a new Pyxis device, Polen said at a Goldman Sachs event last month. The CEO said the launch could cause market share to 'shift incrementally' and presents an opportunity to charge a price premium. Recommended Reading BD plans split from life science business to fuel medtech investment
Yahoo
02-07-2025
- Business
- Yahoo
Alaris Equity Partners Announces Timing of 2025 Q2 Financial Results, Conference Call and Webcast
NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. CALGARY, Alberta, July 02, 2025 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust ("Alaris" or the "Trust") (TSX: is pleased to announce that it will release its financial results for the three and six months ended June 30, 2025 following the closing of regular trading on the Toronto Stock Exchange Thursday, August 7, 2025. Alaris management will host a conference call at 9 am MT (11am ET) the following day, Friday, August 8, 2025 to discuss the financial results and outlook for the Trust. Participants must register for the call using this link: Pre-registration to Q2 to receive the dial-in numbers and unique PIN to access the call seamlessly. It is recommended that you join 10 minutes prior to the event start (although you may register and dial in at any time during the call). Participants can access the webcast here: Q2 webcast. A replay of the webcast will be available two hours after the call and archived on the same web page for six months. Participants can also find the link on our website, stored under the "Investors' section - 'Presentations and Events', at About Alaris The Trust, through its subsidiaries, invests in a diversified group of private businesses ("Private Company Partners") primarily through structured equity. The primary goal of our structured equity investments is to deliver stable and predictable returns to our unitholders through both cash distributions and capital appreciation. This strategy is enhanced by common equity positions, which allow us to generate returns in alignment with the founders of our Private Company Partners. For further information please contact: Investor Relations P: (403) 260-1457 ir@ Alaris Equity Partners Income Trust Suite 250, 333 24th Avenue S.W. Calgary, Alberta T2S 3E6 in to access your portfolio
Globe and Mail
18-06-2025
- Business
- Globe and Mail
Alaris Equity Partners Income Trust Declares Q2 Distribution
NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. CALGARY, Alberta, June 18, 2025 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust ('Alaris' or the 'Trust') (TSX: announces that the Board of Trustees of the Trust (the 'Board') has declared a trust distribution (' Distribution ') of $0.34 per trust unit for the second quarter of 2025, representing $1.36 per unit on an annualized basis. The Distribution is payable on July 15, 2025 to unitholders of record on June 30, 2025. About Alaris: The Trust, through its subsidiaries, invests in a diversified group of private businesses (" Private Company Partners") primarily through structured equity. The primary goal of our structured equity investments is to deliver stable and predictable returns to our unitholders through both cash distributions and capital appreciation. This strategy is enhanced by common equity positions, which allow us to generate returns in alignment with the founders of our Private Company Partners. For further information please contact: Investor Relations P: (403) 260-1457 ir@ Alaris Equity Partners Income Trust Suite 250, 333 24 th Avenue S.W. Calgary, Alberta T2S 3E6
Hamilton Spectator
02-06-2025
- Business
- Hamilton Spectator
Alaris Equity Partners Announces Closing of $80 Million Bought Deal Offering of 6.50% Convertible Unsecured Senior Debentures, and a US$21.5 Million Follow-On Investment in the Shipyard
NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW CALGARY, Alberta, June 02, 2025 (GLOBE NEWSWIRE) — Unless otherwise stated, all numbers in this press release are presented in Canadian dollars. Alaris Equity Partners Income Trust ('Alaris' or the 'Trust') (TSX: is pleased to announce that it has completed its previously announced offering of convertible unsecured senior debentures ('Debentures') with a syndicate of underwriters (the 'Underwriters') led by National Bank Financial, CIBC Capital Markets and Desjardins Capital Markets, and including Acumen Capital Partners, Raymond James Ltd., RBC Capital Markets, Scotiabank, and Cormark Securities Inc. A total of $80 million aggregate principal amount of Debentures were issued at a price of $1,000 per Debenture (the 'Offering'). The Trust has also granted the Underwriters an option to purchase up to an additional $12,000,000 aggregate principal amount of Debentures, on the same terms and conditions, exercisable in whole or in part, from time to time, up to 30 days following the closing of the Offering. The Debentures will bear interest at a rate of 6.50% per annum, payable semi-annually in arrears on June 30 and December 31 of each year commencing on December 31, 2025. The first payment will include accrued and unpaid interest for the period from closing to, but excluding, December 31, 2025. The Debentures will mature on June 30, 2030. The Debentures will commence trading today on the Toronto Stock Exchange under the symbol ' The Trust intends to use the net proceeds of the Offering to partially repay outstanding indebtedness under Alaris' subsidiary's senior debt facility which may be subsequently redrawn and used to fund future investments in new Partner (as defined below) investments or general trust purposes. The Shipyard Follow-On On May 14, 2025, Alaris closed a US$21.5 million follow-on investment into The Shipyard LLC ('The Shipyard') in exchange for additional preferred equity in The Shipyard, which entitles Alaris to an additional annualized distribution of US$3.01 million (the 'Shipyard Distribution'). The Shipyard used the proceeds of the additional investment to fund the purchase price of an acquisition. ABOUT ALARIS The Trust, through its subsidiaries, invests in a diversified group of private businesses ('Partners') primarily through structured equity. The primary goal of our structured equity investments is to deliver stable and predictable returns to our unitholders through both cash distributions and capital appreciation. This strategy is enhanced by common equity positions, which allow us to generate returns in alignment with the founders of our Partners. This news release is not an offer of securities of Alaris for sale in the United States. The Debentures have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and the Debentures may not be offered or sold in the United States except pursuant to an applicable exemption from such registration. No public offering of securities is being made in the United States. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. FORWARD LOOKING STATEMENTS This news release contains forward-looking statements, including forward-looking statements within the meaning of 'safe harbor' provisions under applicable securities laws (' forward-looking statements '). Statements other than statements of historical fact contained in this news release may be forward-looking statements including, without limitation, management's expectations, intentions and beliefs concerning: the use of proceeds of the Offering, the use of the senior debt facility and the Shipyard Distribution. Many of these statements can be identified by words such as 'believe', 'expects', 'will', 'intends', 'projects', 'anticipates', 'estimates', 'continues' or similar words or the negative thereof. There can be no assurance that the plans, intentions or expectations on which these forward-looking statements are based will occur. By their nature, forward-looking statements require Alaris to make assumptions and are subject to inherent risks and uncertainties. Key assumptions include, but are not limited to, assumptions that: Alaris will use the net proceeds from the Offering in the manner described herein, that the Debentures will trade on the TSX consistent with as described herein and that Alaris will receive annual distributions from The Shipyard as set forth herein. Forward-looking statements are subject to risks, uncertainties and assumptions and should not be read as guarantees or assurances of future performance. The actual results of the Trust and the Partners could materially differ from those anticipated in the forward-looking statements contained herein as a result of certain risk factors, including, but not limited to: the use of proceeds from the Offering in a manner that differs than as set forth herein, the ability of The Shipyard to pay distributions and that the listing of the Debentures will not occur in the timeframes set out herein. Additional risks that may cause actual results to vary from those indicated are discussed under the heading 'Risk Factors' and 'Forward Looking Statements' in the Trust's Management Discussion and Analysis for the year ended December 31, 2024, which is filed under the Trust's profile at and on its website at . Readers are cautioned not to place undue reliance on any forward-looking information contained in this news release as a number of factors could cause actual future results, conditions, actions or events to differ materially from the targets, expectations, estimates or intentions expressed in the forward-looking statements. Statements containing forward-looking information reflect management's current beliefs and assumptions based on information in its possession on the date of this news release. Although management believes that the assumptions reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations will prove to be correct. The forward-looking statements contained herein are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this news release are made as of the date of this news release and Alaris does not undertake or assume any obligation to update or revise such statements to reflect new events or circumstances except as expressly required by applicable securities legislation. Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. For further information please contact: ir@ P: (403) 260-1457 Alaris Equity Partners Income Trust Suite 250, 333 24th Avenue S.W. Calgary, Alberta T2S 3E6
